4//SEC Filing
Sevigny Jeffrey 4
Accession 0000950170-25-050557
CIK 0002012593other
Filed
Apr 2, 8:00 PM ET
Accepted
Apr 3, 5:00 PM ET
Size
5.4 KB
Accession
0000950170-25-050557
Insider Transaction Report
Form 4
Sevigny Jeffrey
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-04-01+300,000→ 300,000 totalExercise: $9.56Exp: 2035-04-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option shall vest and become exercisable on March 3, 2026, with the remaining shares vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Rapport Therapeutics, Inc.
CIK 0002012593
Entity typeother
Related Parties
1- filerCIK 0001778483
Filing Metadata
- Form type
- 4
- Filed
- Apr 2, 8:00 PM ET
- Accepted
- Apr 3, 5:00 PM ET
- Size
- 5.4 KB